Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05803902
What this trial is testing

An Evaluation of 9MW1911 Injection in Healthy Subjects

Who this might be right for
AsthmaCOPDAtopic Dermatitis
Mabwell (Shanghai) Bioscience Co., Ltd. 48
Early research (Phase 1)Looking for participantsNCT07558668
What this trial is testing

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Sitryx Therapeutics Ltd 149
Testing effectiveness (Phase 2)Study completedNCT02795832
What this trial is testing

Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ziarco Pharma Ltd 53
Early research (Phase 1)Ended earlyNCT00644514
What this trial is testing

Genetics of Asthma - Bronchoscopy Studies

Who this might be right for
Atopic AsthmaHealthy
John Sundy 17
Early research (Phase 1)Study completedNCT01081691
What this trial is testing

A Study Evaluating Intravenous and Subcutaneous Administration of a Human Monoclonal Antibody (CNTO 5825) in Healthy Volunteers

Who this might be right for
Healthy
Centocor, Inc. 64
Early research (Phase 1)Study completedNCT06009094
What this trial is testing

Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 80
Early research (Phase 1)Study completedNCT06214481
What this trial is testing

Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

Who this might be right for
Atopic Dermatitis
Amgen 20
Early research (Phase 1)Not Yet RecruitingNCT07746817
What this trial is testing

BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy Participants
Bionyra Pharma 56
Early research (Phase 1)Study completedNCT02148744
What this trial is testing

Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis

Who this might be right for
Allergic RhinitisAllergic ConjunctivitisAtopic Dermatitis
Xencor, Inc. 72
Early research (Phase 1)Study completedNCT03514511
What this trial is testing

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 47
Not applicableLooking for participantsNCT06503510
What this trial is testing

Role of Interleukin-13 Pathways on Pain and Itch Sensitivity

Who this might be right for
Itch
Aalborg University 20
Early research (Phase 1)Study completedNCT06787586
What this trial is testing

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

Who this might be right for
Normal VolunteersAtopic Dermatitis (AD)Atopic Eczema+1 more
Attovia Therapeutics Inc 108
Not applicableLooking for participantsNCT05026554
What this trial is testing

Characterization of Chronic Hand Eczema

Who this might be right for
Chronic Hand EczemaAtopic Dermatitis
Dr. Robert Bissonnette 270
Early research (Phase 1)Study completedNCT05099133
What this trial is testing

A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects

Who this might be right for
Atopic Dermatitis
LEO Pharma 24
Early research (Phase 1)Study completedNCT04065633
What this trial is testing

Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation

Who this might be right for
Dermatitis, Atopic
Pfizer 46
Early research (Phase 1)Study completedNCT07264335
What this trial is testing

A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

Who this might be right for
Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 160
Early research (Phase 1)Looking for participantsNCT07235384
What this trial is testing

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd. 84
Early research (Phase 1)UnknownNCT05215808
What this trial is testing

SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects

Who this might be right for
Atopic Dermatitis
Ribon Therapeutics, Inc. 72
Early research (Phase 1)Study completedNCT05114889
What this trial is testing

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Biosion, Inc. 54
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Next Page